Kyle T. Finn

Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients

R Comenzo, Evan Vosburgh, RW Simms et al. · Blood · 1996 · 229 citations · Full text

High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial

Vaishali Sanchorawala, Daniel G. Wright, David C. Seldin et al. · Bone Marrow Transplantation · 2003 · 125 citations

Medicine, High-dose Intravenous Melphalan, Al Amyloidosis +1

Kidney dysfunction during lenalidomide treatment for AL amyloidosis

R. Specter, Vaishali Sanchorawala, David C. Seldin et al. · Nephrology Dialysis Transplantation · 2010 · 112 citations · Full text

Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis

Betül Oran, Karim Malek, Vaishali Sanchorawala et al. · Bone Marrow Transplantation · 2005 · 44 citations

Transplantation, Marrow Transplantation, Al Amyloidosis +10

Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis

Vaishali Sanchorawala, Daniel G. Wright, Karen Quillen et al. · Bone Marrow Transplantation · 2007 · 43 citations

Al Amyloidosis, Tandem Cycles, Stem Cell Transplantation +4